Format

Send to

Choose Destination
Br J Oral Maxillofac Surg. 2018 Jan;56(1):64-66. doi: 10.1016/j.bjoms.2017.08.009. Epub 2017 Nov 27.

Clinical outcome after 36 months of treatment with injections of autologous blood for recurrent dislocation of the temporomandibular joint.

Author information

1
First Department of Oral and Maxillofacial Surgery, Osaka Dental University. Electronic address: hiro-y@cc.osaka-dent.ac.jp.
2
First Department of Oral and Maxillofacial Surgery, Osaka Dental University.
3
Department of Oral Radiology, Osaka Dental University.

Abstract

We investigated the prognosis after three years of treatment for recurrent dislocation of the temporomandibular joint with autologous blood given intravenously in 21 patients with a mean (range) age 64 (17-92) years of whom 16 had coexisting systemic disease. The mean (range) follow up from the first injection was 64 (41-99) months. Eighteen patients had no recurrence during the first 36 months after their first injection, which showed that this minimally-invasive treatment was effective, particularly for those who had conditions that made a mouthpiece or operation unsuitable.

KEYWORDS:

Autologous blood injection (ABI); blood; outpatient; recurrent TMJ dislocation

PMID:
29191683
DOI:
10.1016/j.bjoms.2017.08.009
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center